- $209.92bn
- $232.60bn
- $45.81bn
- 85
- 26
- 60
- 58
REG - Stock Exch Notice - Admission to ISM - 17/04/2024
AnnouncementREG - AstraZeneca PLC - Result of AGM
AnnouncementREG - AstraZeneca PLC - AstraZeneca increases 2024 dividend by 7%
AnnouncementREG - AstraZeneca PLC - Enhertu approved in US for HER2+ solid tumours
AnnouncementREG - AstraZeneca PLC - Imfinzi improved OS & PFS in limited-stage SCLC
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Voydeya approved in US
AnnouncementREG - AstraZeneca PLC - FDA accepts Dato-DXd BLA for breast cancer
AnnouncementREG - AstraZeneca PLC - Ultomiris approved in the US for NMOSD
AnnouncementREG - AstraZeneca PLC - AstraZeneca to acquire Fusion
AnnouncementREG - AstraZeneca PLC - AstraZeneca to acquire Amolyt
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Notice of AGM
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - EMA validates Dato-DXd MAAs for NSQ NSCLC and BC
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Voydeya recommended for EU approval
AnnouncementREG - AstraZeneca PLC - Acquisition of Gracell completed
Announcement